Ascending Dose and Exploratory Expansion Study of DS-3032b, an Oral MDM2 Inhibitor, in Subjects With Relapsed and/or Refractory Multiple Myeloma
Clinical trial NCT02579824 · TERMINATED
Trial details
- NCT number
- NCT02579824
- Sponsor
- M.D. Anderson Cancer Center
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-30
- Primary completion
- 2019-11-07
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.